Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Latest Actos Bladder Cancer Trial Starts in West Virginia
Legal Examiner
Sunday, October 19, 2014 - 10:26am
tags:
Actos, Takeda, diabetes
Sexual Dysfunction Drugs For Women Are About Profit, Not Equality
Huffington Post
Sunday, October 19, 2014 - 10:23am
tags:
female sexual dysfunction
Better Late Than Never: CMS Improves The Doctor Payment Website
WSJ Pharmalot
Saturday, October 18, 2014 - 11:31am
tags:
CMS, Medicare, Medicaid, physician payments, Physician Payment Sunshine Act
MannKind: 5 Potential Technosphere Applications
Seeking Alpha
Saturday, October 18, 2014 - 10:49am
tags:
MannKind, Technosphere
Ebola Drug Race Ramps Up in Earnest
WSJ
Saturday, October 18, 2014 - 10:43am
tags:
Tekmira Pharmaceuticals, Mapp Biopharmaceutical, Chimerix, Ebola, vaccines
Proteon Therapeutics on deck for IPO
Seeking Alpha
Saturday, October 18, 2014 - 10:36am
tags:
Proteon Therapeutics, IPOs
Dept. of Irony: AbbVie Can Take Tax Write-Off for Fees On Busted Shire Deal
WSJ
Saturday, October 18, 2014 - 10:10am
tags:
AbbVie, Shire
Perrigo CEO Constructs "Five Pillars" For Success
Investor's.com
Saturday, October 18, 2014 - 10:09am
tags:
Perrigo
Ultragenyx Reports Data from Sialic Acid Deficiency Study
Yahoo/Zacks
Saturday, October 18, 2014 - 10:03am
tags:
Ultragenyx, SA-ER, hereditary inclusion body myopathy
Will ObamaCare Help McKesson, Other Drug Companies?
Investors.com
Friday, October 17, 2014 - 7:11pm
tags:
Affordable Care Act, McKesson, AmerisourceBergen, Cardinal Health
Gilead's Harvoni Receives Notice of Compliance from Canada
Yahoo/Zacks.com
Friday, October 17, 2014 - 7:08pm
tags:
Gilead Sciences, Harvoni, hepatitis C, Canada
Myriad Gets Reimbursement OK On Prostate Cancer Test
Investors.com
Friday, October 17, 2014 - 7:02pm
tags:
Myriad Genetics, prostate cancer, diagnostics, Medicare
Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit - sources
Yahoo/Reuters
Friday, October 17, 2014 - 6:49pm
tags:
Fresenius, Danone, medical nutrition, M&A
Horizon acquires U.S. rights to osteoarthritis drug
Seeking Alpha
Friday, October 17, 2014 - 10:54am
tags:
Horizon Pharma, Pennsaid, Nuvo Research, osteoarthritis of the knee
FDA facing huge pressure as Ebola worsens
Pharmaphorum
Friday, October 17, 2014 - 10:52am
tags:
FDA, ebola virus
GSK Expects Delayed Production Of Ebola Vaccine
Bidness Etc.
Friday, October 17, 2014 - 10:51am
tags:
GSK, ebola virus, vaccines
NewLink Continues Upward Trajectory On Ebola Scare
Bidness Etc.
Friday, October 17, 2014 - 10:18am
tags:
NewLink Genetics, ebola virus, VSV-EBOV, vaccines
Ethicon injoined from selling ultrasonic surgery device
Seeking Alpha
Friday, October 17, 2014 - 10:15am
tags:
Ethicon, Harmonic ACE +7, devices
Anoro Ellipta beats Spiriva HandiHaler in COPD trial
Seeking Alpha
Friday, October 17, 2014 - 10:12am
tags:
Anoro Ellipta, Spiriva HandiHaler, COPD, GSK, Boehringer Ingelheim
Roche, Merck extend immunotherapy fight to breast cancer
Yahoo/Reuters
Friday, October 17, 2014 - 10:08am
tags:
Roche, Merck, breast cancer, MPDL3280A, Keytruda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.